Theratechnologies reçoit le Prix Innovation RSRI 2023 décerné par le CQDM et l’ADRIQ
24. November 2023 07:30 ET
|
Theratechnologies
MONTRÉAL, 24 nov. 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au...
Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award
24. November 2023 07:30 ET
|
Theratechnologies
MONTREAL, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal
12. Juli 2022 07:30 ET
|
Theratechnologies
MONTREAL, July 12, 2022 (GLOBE NEWSWIRE) -- CQDM, the Quebec Breast Cancer Foundation and Theratechnologies today announced close to CAN $2 million of funding for a collaborative research project...